MRI-based evaluation for predicting pathological response and monitoring reactive angioma evolution in
Luyi Lin1, Jinlong Zheng1,2, Fan Yang3
1Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.
Abstract
No abstract available in PubMed .
Keywords:
BiomarkerMRINeoadjuvant chemoimmunotherapyQuantitative apparent diffusion coefficient histogram metricsTriple-nagative breast cancerMore Related Videos
06:24Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
15.6K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.6K
